1-5 of 5
Manfred Schwab
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

André Oberthuer, Dilafruz Juraeva, Barbara Hero, Ruth Volland, Carolina Sterz, Rene Schmidt, Andreas Faldum, Yvonne Kahlert, Anne Engesser, Shahab Asgharzadeh, Robert Seeger, Miki Ohira, Akira Nakagawara, Paola Scaruffi, Gian Paolo Tonini, Isabelle Janoueix-Lerosey, Olivier Delattre, Gudrun Schleiermacher, Jo Vandesompele, Frank Speleman, Rosa Noguera, Marta Piqueras, Jean Bénard, Alexander Valent, Smadar Avigad, Isaac Yaniv, Richard G. Grundy, Monika Ortmann, Chunxuan Shao, Manfred Schwab, Roland Eils, Thorsten Simon, Jessica Theissen, Frank Berthold, Frank Westermann, Benedikt Brors, Matthias Fischer
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (8): 1904–1915.
https://doi.org/10.1158/1078-0432.CCR-14-0817
Published: 14 April 2015
View article titled, Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers
Open the PDF for Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers in another window
Includes: Supplementary data
Journal Articles

Heterogeneity of the MYCN Oncogene in Neuroblastoma

Jessica Theissen, Marc Boensch, Ruediger Spitz, David Betts, Sabine Stegmaier, Holger Christiansen, Felix Niggli, Freimut Schilling, Manfred Schwab, Thorsten Simon, Frank Westermann, Frank Berthold, Barbara Hero
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (6): 2085–2090.
https://doi.org/10.1158/1078-0432.CCR-08-1648
Published: 16 March 2009
View article titled, Heterogeneity of the <em>MYCN</em> Oncogene in Neuroblastoma
Open the PDF for Heterogeneity of the <em>MYCN</em> Oncogene in Neuroblastoma in another window
Journal Articles

High Skp2 Expression Characterizes High-Risk Neuroblastomas Independent of MYCN Status

Frank Westermann, Kai-Oliver Henrich, Jun S. Wei, Werner Lutz, Matthias Fischer, Rainer König, Ruprecht Wiedemeyer, Volker Ehemann, Benedikt Brors, Karen Ernestus, Ivo Leuschner, Axel Benner, Javed Khan, Manfred Schwab
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (16): 4695–4703.
https://doi.org/10.1158/1078-0432.CCR-06-2818
Published: 15 August 2007
View article titled, High <em>Skp2</em> Expression Characterizes High-Risk Neuroblastomas Independent of <em>MYCN</em> Status
Open the PDF for High <em>Skp2</em> Expression Characterizes High-Risk Neuroblastomas Independent of <em>MYCN</em> Status in another window
Includes: Supplementary data
Journal Articles

Reduced Expression of CAMTA1 Correlates with Adverse Outcome in Neuroblastoma Patients

Kai-Oliver Henrich, Matthias Fischer, Daniel Mertens, Axel Benner, Ruprecht Wiedemeyer, Benedikt Brors, André Oberthuer, Frank Berthold, Jun Stephen Wei, Javed Khan, Manfred Schwab, Frank Westermann
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (1): 131–138.
https://doi.org/10.1158/1078-0432.CCR-05-1431
Published: 05 January 2006
View article titled, Reduced Expression of <em>CAMTA1</em> Correlates with Adverse Outcome in Neuroblastoma Patients
Open the PDF for Reduced Expression of <em>CAMTA1</em> Correlates with Adverse Outcome in Neuroblastoma Patients in another window
Journal Articles

Preclinical Evaluation of the Breast Cancer Cell-Binding Peptide, p160

Vasileios Askoxylakis, Sabine Zitzmann, Walter Mier, Keith Graham, Susanne Krämer, Frederic von Wegner, Rainer H.A. Fink, Manfred Schwab, Michael Eisenhut, Uwe Haberkorn
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (18): 6705–6712.
https://doi.org/10.1158/1078-0432.CCR-05-0432
Published: 15 September 2005
View article titled, Preclinical Evaluation of the Breast Cancer Cell-Binding Peptide, p160
Open the PDF for Preclinical Evaluation of the Breast Cancer Cell-Binding Peptide, p160 in another window